Pembrolizumab in Combination With Olaparib in Advanced BRCA-mutated or HDR-defect Breast Cancer
Clinical trial NCT03025035 · COMPLETED
Trial details
- NCT number
- NCT03025035
- Sponsor
- Yuan Yuan
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-10
- Primary completion
- 2024-10-08
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.